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In a  previous report on the effects of the leukocytosis-  and lymphocytosis- 
promoting factor (LPF)  1 ofBordetella pertussis on cyclic adenosine 3':5'-mono- 
phosphate (cAMP) metabolism, a method for isolation of highly active LPF was 
presented  briefly  (1).  In the  present  communication,  the  results  of further 
studies on the isolation and chemical, immunochemical, and biological proper- 
ties of LPF are described. It has been found that a single moiety is responsible 
for  the  induction  in  mice  of  leukocytosis  with  both  lymphocytosis  and  granulocy- 
tosis,  histamine sensitization,  and hypoglycemia and unresponsiveness  to the 
hyperglycemic effects  of  epinephrine.  In  confirmation  of  our  preliminary  report 
(2),  LPF has  been  found to  be clearly  distinct  from  the  hemagglutinating pili  of 
B.  pertussis,  the  properties  of  which are also  described. 
Materials and Methods 
B. pertussis Cultures.  Strain NIH 114 (3779B), which has been utilized in continuing  studies 
in  this  laboratory was also  employed in  the present investigations.  Lyophilizod samples, obtained 
through the courtesy of  Dr. Charles Manclark, Bureau of  Biologics,  Bethesda, Md., were reconsti- 
tuted in sterile  distilled H~O and plated on Bordet-Gengou  medium  (Clinical Sciences Inc., 
Whippany,  N. J.).  The 2-day growth at 36°C on one Petri dish was harvested in 10 ml of 2% 
casamino acids (technical  grade; Difco Laboratories, Detroit,  Mich.), and 1 ml of  the suspension 
was inoculated into  100 ml of  liquid  medium in i  liter  Blake bottles.  After 2 days of  incubation at 
36°C, 10 ml of  the seed culture (approximately  5 × 10  x°  organJma) was inoculated into 1 liter  of 
liquid medium  in Povitsky bottles  which were then incubated at 35-36°C. In order to provide 
maximum  surface area for aeration, all bottles  were placed in the horizontal position during 
incubation. In  the case of  the 100 ml cultures,  the  depth of  the medium was 1.0  cm and the surface 
area 218 cm2; the values for the 1-1iter  cultures were 2.5 cm and 580 cm  2, respectively. 
The liquid medium  was that previously described (3) except for the omission of an anion 
exchange resin which was found to be unnecessary for  either  optimal growth, maintenance of  the 
Phase I state,  or maximal production of LPF. Culture density was assessed with the National 
Institutes of Health opacity standard, and the criteria  utilized  to determine whether the orga- 
nisms were Phase I included: a homogenous population of  small, gram-negative coccobacilli  and 
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the inability  of  the organisms to propagate on conventional media such as  nutrient or trypticase 
soy agar. 
Animals.  Female mice of  the  Albany strain  were used in  earlier  studies  for  assays of  leukocy- 
tosis,  but more recently 4- to 6-wk-old female CF-1 mice (Carworth Farms, Div. Charles River 
Breeding  Laboratories,  North Wilmington, Mass.)  which  respond in  the  same fashion with  respect 
to  leukocytosis,  have been employed. CF-1 mice were also  employed for  determination of  in vivo 
epinephrine  responsiveness and histamine sensitization.  4- to 6-wk-old female HLA/SW  (ICR) 
mice (Hilltop  Laboratories, Scottsdale,  Pa.)  and CFW  mice (Carworth Farms, Portage, Mich.) 
were also  used in some experiments.  "Nude" mice with a BALB/c background were bred and 
maintained in the Central Animal Service of  the Downstate Medical Center. 
Biological Assays 
LEUKOCYTOSm.  Test material in a  vol of 0.1  ml or 0.2 ml was injected intravenously via a 
lateral tail vein. At intervals,  5  ~l or 10  /~1  of blood  was obtained from the tail and diluted 
appropriately in 3% acetic acid containing crystal violet. The leukocytes were enumerated (leuko- 
cyte count [WBC]) in a hemacytometer. For routine assay of the LPF activity of a given prepara- 
tion, groups of three to five mice were used and WBCs were performed 3 days after injection, a 
time  previously shown to  be  optimal with  respect  to  both  total  leukocytosis  and lymphocytosis (3). 
Differential  counts were performed on films stained with Wright-Giemsa. 
HISTAMINE SENSITIZATION.  After injection ofB. pertussis,  mice and rats which are normally 
resistant to the lethal effects of histamine become highly sensitive (4-7).  Histamine-sensitizing 
factor (HSF) activity was assayed in pertussis-treated mice by injecting the equivalent of 1 mg of 
histamine-free base, as histamine dihydrochloride (sehwarz/Mann Div., Becton, Dickinson & Co., 
Orangeburg, N. Y.),  intraperitoneally in 0.5 ml of isotonic saline and recording the number of 
deaths after 60 rain. 
BLOOD GLUCOSE  AND EPINEPHRIN]$  RESPONSIVENEss.  Blood glucose was measured by the glucose 
oxidase  method  (Worthington  Biochemical Corp.,  Freehold,  N.  J.).  Fasting blood  sugar  was 
determined  after removal of food for 5-6 h  or overnight.  Responsiveness to epinephrine  was 
assayed by determining the blood glucose levels 30 min after the intraperitoneal injection of 5/zg 
of epinephrine (adrenalin HCI; Parke, Davis & Co., Detroit, Mich.) in 0.2 ml of  phosphate-buffered 
saline  (PBS). 
Hemagglutination  and Hemagglutination  Inhibition  (HI).  Hemagglutination was routinely 
performed using chicken erythrocytes (CRBC).  Test samples in a  vol of 0.05 ml were serially 
diluted  twofold in  PBS  in  microtrays  with  U-shaped  wells  (Model  IS-MRC-96,  clear;  Linbro 
Chemical Co.,  New Haven, Conn.)  using the microtiter technique (Cooke Laboratory Products 
Div., Dynatech Laboratories Inc., Alexandria, Va.). Then 0.05 ml of an 0.5% suspension of washed 
CRBC in PBS was added, the trays gently shaken, and hemagglutination recorded after 60 min at 
room temperature. 
HI was performed with  sera heated  at 56°C for 30  rain.  Because of the uniform finding of 
nonspocific  HI in all normal rabbit and human sera tested, the sera were first absorbed with 
kaolin as described by Clarke and Casals (8). The adsorbed sora were then serially diluted twofold 
in a vol of 0.05 ml in borate-saline buffer (9) and then 0.05 ml containing four hemagglutinating 
units was added. After mixing, the trays were held at room temperature for 60 rain, 0.05 ml of 0.5% 
CRBC was next added, and hemagglutination recorded after a further 60 min. 
ImmunologicalProcedures.  Double-diffusion reactions were performed in 0.75% agarose in 0.1 
M Tris-0.5  M  NaC1,  pH 9.0. Microimmunoelectrophoresis was usually carried out in barbital 
buffer, pH 8.2,  ionic strength 0.04 (Behring Diagnostics, American Hoechst Corp., Somerville, 
N. J.) at 90 V for 90 min. 
Antisera against B. pertussis and its products were prepared in rabbits which were repeatedly 
injected  subcutaneously with 1.0 ml of  killed  whole culture.  A useful schedule was to inject  the 
animals three times a week for  3 wk and then wait 1-2 wk and repeat the series  once or twice. 
Serum was obtained 7-10 days after  the last  injection.  Antibody to  purified  LPF was prepared by 
homogenizing the LPF in  complete  Freund's adjuvant (Difco  Laboratories)  and injecting  a total  of 
25  ~g in  multiple 0.2-ml depots.  The injections  were repeated in  3 wk and serum was obtained 10- 
21 days later.  Hyperinunune pertussis  human gamma globulin (Hyland Div.,  Travenol Laborato- 
ries,  Inc.,  Costa Mesa, Calif.  and Cutter Laboratories,  Berkeley, Calif.)  was also  employed. 
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bovine serum albumin as the standard; nitrogen by the ninliydrin  technique (10); carbohydrate by 
the phenol-sulfuric acid method (11); and total  and bound lipid by the method of Marsh and 
Weinstein (12)  after extraction of material into chloroform,  chloroform:methanol, or heptane 
before  and after alkaline hydrolysis. Elemental analyses were performed  by Mr. T. Bella, The 
Rockefeller University, New  York.  Amino acid analyses were  performed  after  hydrolysis of 
samples in vacuo in 6 N HC1 at ll0°C for 16 h, utilizing  a Joelco model JL C-6AH analyzer (Joelco, 
Cranford,  N.  J.).  Dr.  Ronald F.  Rieder,  Downstate Medical Center,  Brooklyn, N.  Y.,  kindly 
assisted in the ,miuo acid determinations. 
Polyacrylamide Gel Electrophoreses.  Analytical gel electrophoresis of undissociated or disso- 
ciated LPF was performed according to methods described by Maizel (13). Gels were stained with 
Coomassie blue and scanned with a soft laser scanner (Biomed Instruments, Inc., Chicago, Ill.). 
Analytical isoelectrofocusing was kindly performed by Dr.  I. Parsa, Downstate Medical Center, 
Brooklyn, N. Y. 
Elution of material in gels was performed  in the following fashion. After electrophoresis, the 
cylindrical gel was cut longitudinally into quarters and one of the slices was stained for a brief 
period and destained electrolyticaUy. The remaining segments were matched to localize the bands 
and then cut transversely in the appropriate areas. The cut portions were homogenized in 4 M 
urea-0.1 M PO~-I M NaCI, pH 6.4, and the gel then removed by centrifugation. 
Electron Microscopy.  Specimens on hydrophilic grids were negatively stained with 2% sodium 
dodecatungstosilicate or 1% ammonium molybdate. The preparations were examined in either a 
Siemens 1A (Siemens Corp.,  Medical/Industrial Groups,  Iselin, N.  J.) or Philips 300  (Philips 
Electronic Instruments, Inc., Mount Vernon, N. Y.) electron microscope. 
Results 
Separation of  LPF from Hemagglutinin (HA).  The basic methodology used 
to harvest and fractionate B. pertussis  supernatant fluids has been described 
previously  (1).  Briefly,  after 5 days of culture,  10% thiomersal in saline was 
added to achieve a final thiomersal concentration of 0.02%. After 24 h at 4°C, the 
bacterial cells were removed by centrifugation and the pH of  the pooled superna- 
tant fluid obtained from 6 to 10 liters of culture was adjusted to pH 6.4 with 1 N 
HC1. Solid (NH4)2SO4 was added to 90% saturation while the pH was maintained 
by the addition of dilute NH4OH. After 18 h at 4°C the precipitate was collected 
by filtration and resuspended in water. The H20 soluble fraction was discarded, 
and after washing the precipitate in 0.15 M NaC1, it was solubilized in 6 ml of 0.1 
M Tris-0.5 M NaCI, pH 10 (Tris-NaC1  buffer). Insoluble inactive material was 
removed by  centrifugation and the  soluble active fraction was layered  on a 
discontinuous CsCI gradient.  The gradient consisted  of  6-rnl  portions  of  CsCI of 
densities  1.5,  1.3,  1.25,  and 1.2 in Tris-NaCl buffer.  The tubes were centrifuged 
in an SW-25 rotor  at 50,000  g for 3.5 h. After centrifugation,  the bulk of  LPF, 
HSF, and HA was found in the 6 ml load vol which was then dialyzed against 
Tris-NaCl buffer. 
Electron  microscopy of  this  fraction  (Fig.  1)  revealed  the  presence of:  filaments 
(pili) measuring 20-25 A  in diameter and of varying lengths (60-100 nm); 
heterogeneous round particles  varying in diameter from 20-35 nm (14);  and, in 
addition,  smaller round particles  were present.  Morphologic heterogeneity was 
paralleled  by immunological heterogeneity since  immunodiffusion analysis  re- 
vealed the presence of  two major precipitin  bands. 
The fraction was then sieved through Sephadex  G-150 (Pharmacia Fine 
Chemicals,  Inc.,  Piscataway,  N. J.),  in a 2.6 cm x 26 cm siliconized  column. 
Elution was at 4°C with Tris-NaCl at a flow rate  of  8-10 ml/h. 2-ml fractions 
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Fro. i.  Negatively  stained  fraction  from  a  CsCI  gradient  containing LPF activity.  Numer- 
ous  pili  (--*),  and  large,  round membranous particles  are  present.  Also  present are  smaller 
round particles. × 140,000. 
elution profile is shown in Fig.  2,  together with the appearance  of molecular 
weight marker substances (dextran blue dye, mol wt 2,000,000;  phosphorylase 
A, mol wt 90,000;  and bovine serum albumin (BSA), mol wt 67,000). 
Three protein peaks were detected. Peak I was excluded from the Sephadex 
and coincided with the elution peak of the excluded dextran blue dye. Peak II 
was eluted after phosphorylase A and in the same region as BSA. The third peak 
had neither biological nor immunological reactivity and will not be considered 
further. Peaks I and II were each concentrated on an Amicon apparatus using a 
PM-10 membrane  (Amicon Corp.,  Scientific Sys. Div.,  Lexington,  Mass.) and 
then tested for HA and LPF activity. 
As can be seen in Table I, the excluded peak I contained a highly potent HA 
but was devoid of LPF activity.  In contrast,  peak II was a  potent inducer of 
leukocytosis but had only minimal hemagglutinating capacity. The increases in 
specific activity over the starting culture supernatant fluid was 40- to 50-fold for 
the HA fraction (peak I) and 25- to 40-fold for the LPF fraction (peak II). 
Properties  of HA.  General properties of the HA were first examined using 
culture supernatant fluids as the source of crude HA. It was found that erythro- 
cytes from a  number of species other than chickens were agglutinated.  These 
included erythrocytes of man  (O negative), rabbit, sheep, guinea pig,  and rat. 
Hemagglutination  was not inhibited by mannose  or a-methylmannoside  (15). 
Treatment  of erythrocytes with crude Vibrio cholerae  neuraminidase  did not 
cause a  reduction in the titer of pertussis HA. Thus,  the receptors for the HA 
were not neuraminidase sensitive. The HA was sensitive to heat with over 90% 
of the activity destroyed in 30 min at 56°C and was inactivated by the proteolytic 
enzymes trypsin and pronase.  However, it was not inactivated by either 0.1% 
formalin or 5.0% phenol after exposure for 48 h  at 4°C. 
HA-inhibition tests were performed using the G-150 peak I HA fraction and it 
was  found  that  antisera  prepared  in  rabbits  against  whole  cultures  of B. 
pertussis had HI titers ranging from 1/40-1/160. It was of note that sera from 12 0.55- 
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Fro.  2.  Sephadex  G-150 column chromatograph  of an LPF-containing  fraction obtained 
from a CsCl gradient. 
TASLE I 
HA and LPF Activity of Sephadex  G-150 Peaks 
Peak  1 HA  unit*  WBC  x 10-SlmmS$ 
~g 
I  0.03  23.7 
II  0.5  182.0 
* Minimal quantity producing complete hemagglutination. 
$ 3 days after the intravenous injection of I pg (normal WBC,  20.5 x 
10-s/ramS). Mean value in four mice. 
immunized children ranging in age from 16 mo to 6 yr had even weaker HI titers 
(less than 1/10). 
The ultrastructural  components of the HA fraction are illustrated in Fig. 3. 
The predominant  structures are the previously noted pili and membrane-like 
components  but the  smaller  particles  were  absent.  The  structured  elements 
were partially resolved by ultracentrifugation.  HA at a concentration of 500 ~g 1488  LE  UKOCYTOSIS-PROMOTING  FACTOR 
FIG.  3.  Electron microscope appearance  of peak I from a  Sephadex G-150  column which 
contained  HA  activity.  Numerous  pili  and  large  membranous  particles  are  present. 
x  140,000. 
FIG.  4.  Supernate of the HA fraction after centrifugation.  Pill are now the predominant 
structures,  x  140,000. 
of protein/ml was centrifuged at 30,000 RPM for 2.5 h  in an SW 39 rotor. The 
supernatant fluid was removed and recentrifuged under the same conditions. 
The pellets were pooled and resuspended to initial volume and the preparations 
analyzed for HA activity, ultrastructural  appearance,  and immunoprecipitin 
reactions.  The specific activity for HA in both the supernate and pellet was 
identical; 0.04/~g produced complete hemagglutination. 
Electron microscopic examination of the supernate revealed mainly pili (Fig. 
4), whereas the pellet contained both pili and membranous particles. Paralleling 
this observation was the finding that both the starting material and the pellet 
contained two immunologically reactive bands, whereas the supernatant frac- 
tion yielded only one prominent band. The combined immunological and ultra- 
structural  findings therefore suggested that the HA activity of B. pertussis 
resided in the pili. 
Properties of  LPF.  When concentrated peak II, at a concentration of 500/~g/ 
ml,  was  tested  against  a  battery  of different  whole  culture  antisera  most 
preparations showed only a single immunoprecipitin  band. Occasionally prepa- 
rations were found to contain a  second immunologically reactive component. 
LPF was readily removed from this component by dialyzing the preparation 
against 400 volumes of PBS at 4°C for 5 h. The precipitate which formed was 
dissolved in Tris-NaC1 buffer and contained only LPF, whereas the PBS super- 
nate contained both components. Highly purified LPF with only a  trace of the STEPHEN  I.  MORSE  AND  JANE  H.  MORSE  1489 
FIG. 5.  Well 1,  contains anti-LPF antiserum; well 2,  the  CsCl  load  fraction  before  chroma- 
tography on Sephadex G-150; well 3, whole antipertussis  antiserum;  and well 4, purified 
LPF.  Note that the pertussis antiserum  recognizes only one immunologically  reactive 
component in  LPF, and that  anti-LPF antiserum reacts  with  only  a  single  component in  the 
crude material. 
second component could be prepared by dialyzing the PBS supernatant fluid 
against large volumes of H20 for 18 h and harvesting the precipitate. The water- 
soluble material had no LPF activity. 
LPF preparations tended beth to aggregate and to lose activity. When 4 M 
urea-0.1 M PO4-1 M NaC1 with an apparent pH of 6.4 (16) was utilized, aggrega- 
tion was minimized and LPF solutions in this medium retained activity when 
stored at concentrations of 100-700 ~g/ml for periods of 6-10 wk; in contrast, 
LPF activity was rapidly lost in 2.5 M guanidine in the same buffer. 
Homogeneity of LPF.  Homogeneity of LPF prepared in this fashion was 
analyzed by immunological, physical, and electron microscopical techniques. 
In double-diffusion analyses, the isolated LPF gave a  single immunological 
precipitin band when reacted over a wide range of concentrations with hetero- 
specific antipertussis antibody. Similarly, at various dilutions of antiserum and 
a constant antigen amount, only a single immunoprecipitin band was detected. 
Antisera raised to the isolated LPF also showed a single band on Ouchterlony 
analysis against LPF and recognized only a single immunoreactive  substance in 
crude concentrated pertussis fractions in which other components of the orga- 
nism as well as LPF were present (Fig.  5).  Human hyperimmune pertussis 
gamma globulin also produced a single band in double-diffusion reactions with 
LPF, while pooled normal human gamma globulin caused only a  very weak 
reaction (Fig. 6). Normal rabbit serum did not precipitate LPF. Immunoelectro- 
phoretic analyses also showed that when LPF was electrophoresed and then 
heterospecific pertussis antisera or LPF antisera added, a single immunologic 
component was detected (Fig. 7). In some preparations a second arc which fused 
with the main precipitin arc was present. However, under a variety of different 
conditions the arcs never completely crossed and always fused, indicating a 
reaction of partial identity. These findings suggest that some degradation of the 
LPF molecule may have taken place (vide infra). 
A number of different acrylamide  gel concentrations and buffers were utilized 
in attempts to analyze undissociated LPF.  Irrespective of gel concentrations, 
only trace amounts of material entered when the buffer pH was neutral or 
alkaline. The most useful system proved to be that composed of 5% gels and the 
pH 4.5 buffer described by Reisfeld et al.  (17) but without the stacking gel. 1490  LE  UKOCYTOSIS-PROMOTING  FACTOR 
FIG. 6.  The center  well  contains  purified  LPF. Well 1  contains  normal rabbit  serum and 
well  2  contains  pooled normal human gamma globulin.  Different  batches of  human hyper- 
immune pertussis  gamma globulin  are  present  in  wells  3  and  4,  while  anti-LPF  antiserum 
is  in  well  5 and antipertussis  antiserum  is  in  well  6. 
FIG.  7.  The top and bottom wells contain two different preparations  of LPF which were 
subject  to  electrophoresis  before  the  addition  of antipertussis  antiserum  to  the  center 
trough. 
Under these conditions, the vast bulk of the material was present as a  single 
band with one or two shoulders toward the cathodal end. It was believed that the 
shoulders represented degradative products of LPF since when stored LPF, 
which had lost activity, was rerun, the peak shifted toward the cathode without 
apparent loss of total protein (Fig. 8). 
Isoelectric focussing analysis of LPF revealed four minor components together 
with a major peak and its shoulder which had isoelectric points of  approximately 
9.4-9.6. These last, on the basis of electrophoretic properties, most likely repre- 
sented the major peak with its shoulder seen in acrylamide gels. 
Immunological reactivity of undissociated material in the analytical poly- 
acrylamide gels was studied by electrophoresing LPF, cutting the gel length- 
wise in half, and staining one half. The other half was embedded in agarose. 
After, 30-min troughs were cut in the agarose parallel to and 0.5 cm from the 
gel.  One  trough  was  filled  with  normal  rabbit  serum  and  the  other  with 
antipertussis antiserum. A single immunoprecipitin band coinciding with the 
major peak was found. 
Together these observations indicated that the LPF preparation consisted of a 
major fraction  which accounted for  at  least  70-80%  of the  protein present, STEPHEN  I.  MORSE  AND  JANE  H.  MORSE  1491 
FIG.  8.  Polyacrylamide  gel  electrophoretic  protein pattern  of LPF.  Upper  two  panels: 
densitometric  scan  and  stained  gel  of active  LPF.  Lower  two  panels:  stained  gel  and 
densitometric scan of the same LPF which had become inactive on storage. 
depending upon the preparation, and that there was an immunoreactive sub- 
stance corresponding to this peak. There was also evidence that the heterogene- 
ity  observed  was  related,  at  least  in  part,  to  the  presence  of degraded  or 
denatured LPF. 
As illustrated in Figs. 9 and 10 the purified preparations of LPF contained 
round particles,  usually ringshaped,  which measured 75-80  /k  in  diameter. 
Although the ring or doughnut structure predominated, occasional round parti- 
cles were noted which lacked the central hole. Each ring was composed of  four to 
five round subunits measuring 28/k in diameter. Occasionally the subunits gave 
the appearance of projecting spikes. The preparations in urea, also found to be 
biologically active,  were the  most helpful in providing particles  of smallest 
uniform size.  Frequently, preparations in borate or Tris buffer, especially in 
high concentration, contained large aggregates of the 75-80/k ring structures so 
that the smallest uniform unit was hard to ascertain. 
A number of different LPF preparations were analyzed by polyacrylamide gel 
electrophoresis in 10% running gels after dissociation by boiling for 1 min in 4 M 
urea, 1% sodium dodecyl sulfate (SDS), and 0.2 M 2-mercaptoethanol (12). In 
each instance four polypeptides were detected (Fig.  11). Utilizing a  standard 
solution containing bovine serum albumin, mol wt 67,000; ovalbumin, mol wt 
45,000; chymotrypsinogen, mol wt 25,000; and RNase A, mol wt 13,700, the mol 
wt of the polypeptides were determined to be 23,500,  19,300, 17,400, and 13,400. 
The minimal mean mol wt of LPF as determined by this method, assuming that 
the molecule is made up of one each of the polypeptides, is 73,600, which is in 
reasonably good agreement with that estimated by molecular sieving on Sepha- 
dex G-150.  However, there is preliminary evidence that the lowest molecular 
weight component  is present in twice the molar proportions of  the other polypep- 
tides, which, if confirmed, would place the minimum mol wt by this technique at 
approximately 87,000. 1492  LEUKOCYTOSIS-PROMOTING  FACTOR 
Fins. 9 and I0. Electron micrograph of  purified  LPF. Fig.  9, × 400,000.  Fig.  I0, × 200,000. 
Arrows denote molecules corresponding  to  LPF activity.  Note the absence of  pili. 
FIG. 11.  Polyacrylamide  gel electrophoresis  of LPF dissociated  in SDS and 2-mercaptoeth- 
anol. 
Since the  amino  acid  sequences of the  subunits  of LPF are unknown  it  is 
difficult  to  be  sure  how the  packing  of the  amino  acids  takes  place  in  the 
individual subunits. The finding of four bands on SDS gel, with the possibility 
that the smallest band is present in twice the concentration of the other three, is 
in agreement with the electron microscope picture of four to five small subunits. STEPHEN  I.  MORSE  AND  JANE  H.  MORSE  1493 
TABv.E II 
Amino Acid Corn ~osition of LPF 
Amino Acid  ~M per 100  Amino Acid  ~M per 100 
~M  ~M 
Lysine  5.0 
Histidine  1.3 
Arginine  6.2 
Aspartic acid  8.1 
Threonine  6.5 
Serine  6.7 
Glutamic acid  9.5 
Proline  7.0 
Glycine  10.4 
Alanine  12.2 
1/2 Cystine  0.8 
Valine  4.6 
Methionine  2.4 
Isoleucine  3.2 
Leucine  8.1 
Tyrosine  4.5 
Phenylalanine  3.5 
Chemical Analysis of  LPF.  Carbohydrate was not detected at the 1% limit of 
the  analysis utilized,  and  lipid was not found either before or after alkaline 
hydrolysis at a  limit of less than 0.5%. The UV absorption spectrum of an 800 
~g/ml solution of LPF revealed a peak at 280 nm but not at 260 nm, indicating 
the absence of nucleic acid.  A  representative amino acid analysis is shown in 
Table II.  No  amino  sugars  were detected.  The  elemental  analyses  were:  N, 
14.5%;  C, 47.9%; and H, 6.5%. 
Biological Properties of Purified LPF: Leukocytosis and Lymphocytosis.  As 
little  as  0.02  ~g  of LPF  protein  when  injected  intravenously  resulted  in  a 
significant leukocytosis 3 days after inoculation (Table III). In Fig. 12 the time- 
course of the response to 0.5 ~g of LPF is depicted in respect to the total WBC 
and the number of circulating lymphocytes and polymorphonuclear leukocytes 
(PMNs). It can be seen that as early as 6 h after injection of LPF, there was an 
increase in all three parameters which gradually rose to a peak between the 3rd 
and  5th  day after injection.  By the  7th  day after inoculation,  the  cell  count 
values began to decrease, but normal values were not reached until the 3rd or 
4th wk. 
When higher doses of LPF were used it was found that with doses of 0.5, 1.0, or 
2.0 ~g there was little difference in the total lymphocyte counts 3 days after 
injection, although the total WBC and PMN counts were higher in the groups 
receiving  1.0  or  2.0  ~g.  When  4  ~g  of LPF  was  given,  however,  beth  the 
lymphocyte and PMN responses were greater. During the first 3 days there was 
no mortality and all groups showed weight gain, although this was slightly less 
in the groups receiving the two highest doses. By the 7th day after injection, two 
of four  and  one  of four mice  which  had  received 4  ~g  and  2.0  ~g  of LPF, 
respectively, had died. There was marked weight loss in the surviving animals 
in these two groups. Moreover, in contrast to the observations in animals given 
lower  doses of LPF  the  number  of circulating  lymphocytes and  PMNs  had 
markedly increased.  By the 21st day, all of the mice that had received 4 ~g of 
LPF and three of the four which had received 2 ~g were dead.  There was no 
mortality in the groups receiving 1 [g or less and the changes in weight were 
equal to those in the control mice. Thus at high doses of LPF, in addition to 
toxicity, there was a  shift in the time, as well as in the magnitude of the peak 
response, rather than simply a heightened response at the earlier time period. 
The question of the kinds of lymphocytes, T cells and]or B cells, responding to 1494  LEUKOCYTOSIS-PROMOTING  FACTOR 
TABLE  III 
Leukocyte  Response  of Mice to LPF 
LPF  WBC  x  10-3/mm  3 
/~g 
0.5  159.2  _  10.6 
0.1  85.4 _+ 8.3 
0.02  35.2  _+ 5.2 
None  15.7  _+ 3.4 
Groups of four CF-1 mice were injected intravenously with LPF  and 
leukocyte counts were performed 3 days later. 
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The leukocyte response of mice to the intravenous injection of 0.5/~g of LPF.  FIG.  12. 
LPF was investigated. In preliminary experiments performed in cooperation 
with Doctors C.  Bianco and V. Nussenzweig, New York University School of 
Medicine, New York, it was found that B lymphocytes  as well as T lymphocytes 
were both increased in the blood and although T cells were still the preponder- 
ant cell, the relative increase in B lymphocytes was greater. This change was 
accompanied by a relatively greater depletion of B cells in the spleen. 
In order to further study the effect of LPF on B lymphocytes, congenitally 
athymic "nude" mice, which lack T cells, were utilized. It can be seen in Table 
IV that homozygous nu/nu mice responded with a leukocytosis which averaged 
5.4 times base line values and that the number of circulating lymphocytes and 
PMNs increased 4.9- and 7.7-fold, respectively. The overall response to this dose 
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TABLE IV 
Effect of LPF on the Blood Leukocytes  of Nude Mice 
1495 
Mouse Strain  Day  WBC*  No. of  lympho-  No. of  PMNs* 
cyte8* 
BALB/c  0  8.9 +- 2.7  6.7  _  1.8  1.8  -+ 0.8 
1  26.6 __  6.4  20.8  +  5.5  4.6 _+  1.4 
3  63.3 +_  3.3  49.9 __  6.3  9.7 +- 3.6 
7  47.3  _  5.3  36.9 _+  1.8  8.0 --- 3.9 
nu/BALB 
nu/nu 
0  13.8 ___  2.1  11.4  _  2.2  2.0 _  0.4 
1  31.8 _+  5.0  26.2 _  3.1  4.3  ___  1.4 
3  39.7  _  7.0  33.0 _+  6.2  5.7  +-  1.9 
7  28.3  _  5.4  22.7  _  3.9  4.0 _+  1.3 
0  7.9 -+ 0.5  6.0 +_  1.5  1.4 _+  1.1 
1  21.7  _  8.7  14.5 _+  5.1  6.0 _  3.7 
3  42.6  _+  3.4  29.5 _+  1.4  10.8 _+  4.8 
7  35.1  _  7.6  27.2  _+  7.6  6.2 _+  2.6 
Mice in  groups of  four  were injected  intraperitoneally  with 
performed at intervals. 
* Number  of circulating cells x  10-S/mm  s  _+  1 SD. 
0.5 Pa of LPF and leukocyte counts 
of LPF  was  less  than  usually  observed because  the  material  was  injected 
intraperitoneally,  a less effective route than the intravenous one. 
Histamine Sensitization.  Several different strains of mice were tested for 
their ability to be sensitized to the lethal effect of I mg of histamine by LPF. A 
dose of 10 mg of histamine was insufficient to kill normal mice of any of these 
strains  but the  injection of 0.5  gg of LPF 3 days before challenge markedly 
increased their sensitivity and all were killed by i mg of  histamine. The dose of 
LPF required to induce sensitization to this dose of histamine in 50% of chal- 
lenge mice (SD5o) varied with the mouse strain being tested as shown in Table 
V; the highest SDso of LPF was 0.33 gg for Albany mice and the lowest was 0.01 
/~g  for  CF-1 mice. The differences  in capacity  to be sensitized  to histamine by 
LPF did  not  lie  in  intrinsic  susceptibility  of  untreated mice to  the amine. Thus 
while  all  of  the mouse strains  tolerated  a dose of  10  mg of  histamine, 20  mg was 
lethal  for  100% of  Albany strain  mice  for  which  the  SDso  of  LPF was  the  highest, 
as  well  as  for  CF-1 mice  for  which the  SDso  was  the  lowest,  but  this  dose  was  not 
lethal  for  normal HLA/SW  mice which were also  readily  sensitized  by LPF. 
The optimal time of  sensitization  of  CF-1 mice was 3-5 days ai~r  injection  of 
LPF. At  2  wk, sensitization  was  diminished  and  at  4  wk none  of  five  mice  which 
had received  0.5/~g of  LPF were killed  by 1 mg of  histamine. 
Epinephrine Refractory  Hypoglycemia.  It is known that injection  of B. 
pertussis  cells  into  experimental animals results  in hypoglycemia and a de- 
creased responsiveness to epinephrine as measured by a lack of  elevation  of 
blood sugar after  injection  of  the catecholarnine  (18-20).  Table VI presents  the 
results of a representative  experiment in which various doses of LPF were 
injected  intravenously into  CF-1 mice. 3 days later  the blood sugar was deter- 
mined in  the  fasting  state  and  30  rain  after  the intraperitoneal  injection  of  5 fig 
of epinephrine. It can be seen that there was no hyperglycemic response to 1496  LEUKOCYTOSIS-PROMOTING  FACTOR 
TABLE  V 
50 Percent Sensitizing Dose of LPF for Histamine Lethality in 
Various Strains of Mice 
Mouse strain 
Albany  CF-W  HLA/SW  CF-1 
SDso (~g)*  0.33  0.05  0.03  0.01 
3 days after  the intravenous  injection  of various amounts of LPF, 
groups of  five  mice were injected  intraperitoneally  with an amount of 
histamine diHCl equivalent to 1 mg of  histamine base. Deaths were 
recorded 60 min later. 
* Dose  of  LPF  required to  sensitize  50%  of  the  mice to  the  lethal  effect  of 
1 mg of  histamine. 
TABLE  VI 
The Effect of LPF on Epinephrine Responsiveness 
LPF Dose 
Blood glucose (mg %) 
30 min after epineph- 
Fasting  rine 
~g 
1.0  96.8  -+  5.8  67.0  -+  19.4 
0.5  83.8  _+  7.4  87.5  _+  11.2 
0.1  82.8  _  5.0  92.0  +_  7.8 
0.02  89.5  -+ 4.8  109.8  -+  7.2 
None  102.5  _+  10.9  216.5  -+  27.8 
3 days after the intravenous  inoculation of LPF, the fasting blood 
glucose was determined in groups of four CF-1 mice. Then, 5 big of 
epinephrine  was injected  intraperitoneally and the blood glucose was 
determined 30 min later.  Values are the means -+ one standard devia- 
tion. 
epinephrine in mice which had received between 0.1 and 1.0/~g of LPF and only 
a minimal response, compared to that found in control mice, in those which had 
received 0.02/~g of LPF. In the unresponsive mice a depression of the fasting 
blood glucose was also observed.  When  0.5  ~g of LPF was injected intrave- 
nously, the lack of responsiveness to epinephrine persisted unaltered at 2 wk 
and was still less than 50% of that in control animals at 1 mo. 
It thus appeared that a single moiety had both LPF and HSF activity, and, in 
addition,  was able  to block  the  increment  in blood glucose which  normally 
follows the administration  of epinephrine.  Further evidence for the unity of 
these reactions was obtained when it was found that all three activities were 
present  in  the  eluate  of the  major  band  appearing  on  polyacrylamide  gel 
electrophoresis and not in any other fraction.  In addition,  all three reactions 
were blocked  beth by  prior incubation  of LPF  with monospecific antiserum 
prepared against the isolated compound (Table VII), and by in vivo injection of 
the antiserum. 
Discussion 
Phase I cells of B. pertussis  and their products induce a number of diverse 
effects in experimental  animals  (reviewed in references 5,  7,  21,  22).  Among STEPHEN  I.  MORSE  AND  JANE  H.  MORSE  1497 
TABLE  VII 
The Effect of Antiserum on the Ability of LPF to Induce Leukocytosis, Histamine 
Sensitization, and Fasting Hypoglycemia and Epinephrine Unresponsiveness 
Serum  WBC × 10-3/mm  s 
Histamine 
deaths/ 
total 
Blood  glucose  (rag  %) 
Fasting  After  epinephrine 
None  72.0 _+ 15.4  4/4  103 --- 1.48  112 _.+. 16.4 
Normal  96.5 _+ 14.8  4/4  99 +_ 5.4  99 _+ 8.9 
Anti-LPF  18.5 --- 14.5  0/4  133 _+ 5.9  191 _ 42.3 
Control  13.1 _+ 3.8  0/4  146 -+ 14.7  214 _+ 21.9 
LPF was incubated for 18 h at 4°C with normal rabbit serum, rabbit anti-LPF serum, or buffer 
alone. After centrifugation, 0.1 ml of the supernatant fluid was injected intravenously into CF-1 
mice. 3 days later leukocyte counts, sensitization to the lethal effects of 1 nag of  histamine, and the 
fasting blood glucose and blood glucose response to 5/~g of epinephrine were determined. The dose 
of LPF injected was greater than five times that required to produce leukecytesis and unrespon- 
siveness to epinephrine, and 40 SDsos with respect to histamine sensitization. 
these effects  are: lethality and dermonecrosis caused by a heat-labile compo- 
nent(s);  responses, such as fever,  characteristic  of  the lipopolysaccharide endo- 
toxin moiety of  the cell  walls of  gram-negative organisms; sensitization  to the 
lethal  effects  of  the pharmacologic agents histamine and serotonin, as well as  to 
such nonspecific stresses  as cold,  endotoxic shock, and peptone shock; enhance- 
ment of anaphylaxis; immunopotentiation  with respect to conventional anti- 
body, homocytotropic antibody, and delayed hypersensitivity;  hypoglycemia and 
decreased hyperglycemic response to epinephrine; and leukocytosis with a pre- 
dominating lymphocytosis.  In addition, it  is  clear  that whole cells  and/or crude 
extracts of Phase I organisms induce protective immunity  against pertussis, 
both in animals and man. 
Phenomena  exhibited in vitro  are hemolysis, hemagglutination, and inhibi- 
tion  of  isoproterenol and prostaglandin El stimulation of  cAMP  accumulation in 
human  lymphocytes (1).  Little definitive information exists on the nature  and 
the interrelationships of the components responsible for these reactions with the 
notable  exception  of the  endotoxin  complex  which  seems  to  have  the  same 
general structural and biological activities of other compounds of this type (23- 
25). 
Over the  last  several  years  we  have  been  engaged  in  studies  designed  to 
isolate and characterize the factor that induces leukocytosis with a predominant 
lymphocytosis, LPF, and to determine whether LPF has other biological activi- 
ties known to be induced by B. pertussis.  In initial studies, using supernatant 
fluids obtained from cultures grown in a  dializable medium, it was found that 
LPF  activity  was  concentrated  in  a  cesium  chloride  gradient  fraction  which 
contained as its dominant element filaments measuring 20 A  in diameter and 
40-70  ~m in length  (14).  This same fraction had marked histamine-sensitizing 
activity  and  was  hemagglutinating.  When  such  CsC1  fractions  were  passed 
through Sephadex G-150, the filaments and hemagglutinating properties were 
excluded from the gel and clearly separated from LPF activity as well as from 
HSF (12). The HA found in the void volume was markedly sensitive to heat and 
to proteolytic enzymes. Differential  centrifugation strongly suggested that the 
hemagglutinating  properties  did  reside  in  the  filamentous  particles.  These 1498  LEUKOCYTOSIS-PROMOTING  FACTOR 
results are consistent with the findings of Sato and his colleagues (26-28)  but 
they also suggested that the filaments were identical with LPF and HSF, an 
observation that is not confirmed  by the present studies. They also proposed that 
the filaments can induce protection against experimental pertussis, an observa- 
tion which preliminary results in our laboratory tend to verify. 
The filaments are found on the surface of the organisms early in growth in 
both liquid and solid culture and then in the extracellular environment (14, 28). 
The same is true for the HA (29). Although in our initial studies the terms "pili" 
and "fimbriae" were avoided because of the narrower diameter of the filaments 
(20 A) compared with pili of other organisms (30) their ultrastructure, localiza- 
tion,  protein nature,  and hemagglutinating ability would seem to make the 
terms appropriate. 
The LPF, in contrast to HA, entered Sephadex Go150 and was eluted in the 
same region as BSA. LPF contained 14.5% nitrogen and appears to be protein in 
nature. In this regard, it is of note that despite exhaustive studies, lipid was not 
found. This is in striking contrast to the results of Lehrer and co-workers who 
reported the isolation of a homogeneous product from cells ofB. pertuss/s which 
had LPF as well as HSF activity and which contained greater than 50% lipid 
(16). In their filament-rich preparations with LPF activity Sate and Arai (26) 
also reported the presence of 17.5% lipid, and Munoz and Hestekin (31) found 
28.4%  lipid  in partially purified HSF,  but in  these cases the products were 
clearly heterogenous. 
Lehrer et al. (16) used whole cells as starting material, and it is possible that 
their  preparations were contaminated with lipopolysaccharide  endotoxin. It is 
also  possible  that when LPF is  attached to  the cell  it  is  bound to  lipid  and that 
spontaneous release  of  the material involves  dissociation  of  a  protein-lipid  bond. 
Another difference  in  the chemical nature of  the two  preparations  is  that  Lehrer 
et  al. (16)  could not  detect  any sulfur-containing  amino adds, whereas the LPF 
isolated  in  this  laboratory  contained small  amounts of  both  cysteine  and  methio- 
nine. 
LPF was found to consist  of four polypeptide chains and the tool wt as 
determined  by  acrylamide  gel  electrophoresis was  approximately  72,000, 
whereas a value of  approximately 67,000  was found using Sephadex chromatog- 
raphy. However, if  the finding  of  2 tool  of  the lowest molecular weight peptide 
for  each one of  the others  is  confirmed then the minimal tool  wt as determined 
by gel analysis  would be 86,000.  It  is  of  interest  that the electron  microscopical 
appearance of  LPF is commensurate with a structure  composed of  four  or five 
subunits. 
When as little  as  0.02  IZg of LPF  was injected intravenously into  mice, a 
significant leukocytosis was found 3 days later. Optimal responses at this time 
period were obtained when doses in the range of 0.1-1.0  tzg were used and no 
toxicity was seen; neither lethality nor weight loss in excess of control mice was 
observed. At doses of 2-4 #ag, the peak response was shifted to a later time period 
and beth weight loss and lethality occurred. 
When 0.5/~g of LPF was inoculated, a leukocytosis was observed as early as 6 
h later and both the circulating lymphocytes and granulocytes were increased in 
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of circulating leukocytes had decreased and during the next 2-3  wk normal 
values were achieved. The changes in total leukocyte  count and in the number of 
lymphocytes and PMNs were essentially parallel. 
It  was striking that the  early,  transient,  polymorphonuclear leukocytosis 
previously noted 6 h  after injection of crude supernatant fluids was no longer 
found (3). It is probable that this reaction was due to contaminating endotoxin, a 
thesis supported by the morphologic finding of material in crude superuatant 
fluids which appeared to be derived from extrusions of the cell wall (14). The 
isolated LPF was free of lipopolysaccharide endotoxin by chemical and electron 
microscopical criteria. Moreover, anti-LPF antiserum did not react with pertus- 
sis endotexin prepared by the phenol-water technique. 
LPF  increased the  number  of both  circulating B  cells  and  T  cells.  The 
increment in circulating lymphocytes in nude mice, which lack T  cells,  was 
more striking than found in the studies of Wortis  (32) and Finger et al.  (33). 
These workers used whole B. pertussis cells and there may be differences in the 
responsiveness of nude mice to intact cells and to soluble products. In addition to 
thymus aplasia  of the  nude  mice  employed in  these  studies,  confirmatory 
evidence of their lack of T cells was derived from the unresponsiveness of either 
their spleen cells or lymph node cells to T-cell mitogens such as phytohemagglu- 
tinin (PHA) and concanavalin A  (Con A),  whereas these cells did undergo a 
marked proliferative response to endotoxin, a B-cell mitogen. It was also clear 
that LPF did not induce maturation of precursor T cells into functional T cells, 
since the  cells  at  the  height of the  reaction also  did  not respond to  PHA, 
although they still responded to endotoxin. 
In addition to its marked capacity to induce leukocytosis and lymphocytosis, 
LPF  was  also  extremely potent  in  sensitizing mice to  the  lethal  effects of 
histamine. Depending upon the mouse strain used, the SD~o for 1 mg of hista- 
mine base ranged from 0.01 to 0.33 ~g of LPF. As in the case of leukocytosis, 
peak sensitization was observed 3-5 days after injection of LPF, and the respon- 
siveness decreased over the next several weeks. 
The LPF preparations were also exceedingly active in inhibiting the incre- 
ment in blood glucose which normally follows the injection of 5 ~g of epineph- 
rine into  fasting animals.  Although complete end-point titrations were not 
performed, when 0.02 ~g of LPF  was injected intravenously there was only 
minimal responsiveness to epinephrine 3 days later. In addition, fasting hypo- 
glycemia was found after administration of optimal doses of LPF. 
Certain general findings, such as the time of peak response and the concord- 
ance of relative activities in a given preparation had suggested that the three 
biological activities-leukocytosis and lymphocytosis, histamine sensitization, 
and hypoglycemia  and refractoriness to epinephrine-  were produced by a single 
product of B. pertussis. 
Critical evidence in favor of a single responsible substance was obtained in 
two different ways. Firstly, it was found that all three activities of LPF were 
abolished by an  antiserum which recognized only a  single immunoreactive 
substance. Most convincing, was that the eluate of a single band on gel electro- 
phoresis produced the three phenomena. 
It seems probable that LPF is also responsible for the elicitation of enhanced 1500  LE  UKOCYTOSIS-PROMOTING  FACTOR 
sensitivity to serotonin and nonspecific stress which usually accompany hista- 
mine sensitization (5, 7). Lehrer et al.  (16, 34), as well as Tada et al.  (35) have 
also reported that preparations rich in LPF enhance the production of reaginic, 
but not of conventional, antibody to ovalbumin. We have not as yet examined 
the ability of purified LPF to increase the homocytotropic antibody response. 
Recently, we have found that LPF has still another biological activity; it is an 
exceedingly effective mitogen for murine T  lymphocytes (36)  as  well  as  for 
nonimmune human lymphocytes (J.  H.  Morse, A.  S.  Kong, and S. I.  Morse, 
unpublished observations). 
With such a diversity of activities it will be of great importance to determine 
precisely the mechanism(s) of action of LPF and particularly whether a  single 
common reaction induces the range of observed biological effects. From the 
evidence at hand, further investigation of the relationship between LPF and 
cyclic nucleotides  is  certainly warranted.  It  is  known  that  both  histamine 
sensitization (37) and refractoriness to the hyperglycemic effect of epinephrine 
(38) can be produced by beta adrenergic antagonists, and in turn many of the 
effects of beta adrenergic agonists  are mediated by cAMP.  In addition  LPF 
blocks the intracellular accumulation of cAMP which is normally stimulated by 
beta adrenergic agents such as isoproterenol (1). However, the reaction is more 
complex than that of  beta adrenergic blockade, since the ability of  prostaglandin 
E1 to increase cAMP is also inhibited. It is thus possible that LPF has a direct 
effect on adenylate cyclase, the activity of which appears to be decreased in the 
spleens of pertussis-treated mice (39). An alternative hypothesis is that cGMP 
metabolism is affected, with a consequent reciprocal effect on cAMP. It would be 
of great interest if a  role for cyclic nucleotides in the control of lymphocyte 
recirculation is revealed in the ongoing studies of the mechanism of LPF action. 
Summary 
The  leukocytosis- and lymphocytosis-promoting factor  (LPF)  of Bordetella 
pertussis  has  been isolated to  near homogeneity by physical,  chemical,  and 
electron microscopical criteria.  LPF contains 14.5% nitrogen and is lipid and 
carbohydrate free. It is apparently composed of four polypeptide subunits. 
LPF caused leukocytosis and lymphocytosis in "nude" as well as in normal 
mice. In addition, purified LPF also induced histamine sensitization and hypo- 
glycemia and refractoriness to the hyperglycemic effect of epinephrine. A mono- 
specific LPF  antiserum blocked  these reactions as  well as  leukocytosis and 
lymphocytosis. LPF  is  clearly distinct from the hemagglutinating pili  of B. 
pertussis. 
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